Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT03720704

Post-Market Registry of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Implanted in Peripheral Vessels

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
280 (actual)
Sponsor
W.L.Gore & Associates · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The primary objective of the VBX 17-04 registry is to collect post-market safety and performance data of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) in peripheral vessels in patients who require interventional treatment

Conditions

Interventions

TypeNameDescription
DEVICEGORE VIABAHN VBX Balloon Expandable EndoprosthesisGORE VIABAHN VBX Balloon Expandable Endoprosthesis will be implanted in peripheral vessels in patients who require interventional treatment.

Timeline

Start date
2018-12-18
Primary completion
2022-04-13
Completion
2027-07-01
First posted
2018-10-25
Last updated
2026-04-14
Results posted
2024-02-16

Locations

11 sites across 5 countries: France, Germany, Italy, Netherlands, Spain

Regulatory

Source: ClinicalTrials.gov record NCT03720704. Inclusion in this directory is not an endorsement.